Exhibitor Product Theater - Identifying and Treating Patients with Moderately to Severely Active UC

Michael V. Chiorean, MD, FACG

This program is sponsored by Bristol Myers Squibb.

Join Bristol Myers Squibb for a conversation with Dr. Chiorean on patient identification and treatment considerations for patients with moderately to severely active UC.

Open to all ACG 2022 attendees, industry-sponsored Product Theater provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibit Product Theater presentations.